Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 43.5414.3510.2811.5519.03

What is the latest EV/Core EBITDA ratio of VAISHALI PHARMA ?

The latest EV/Core EBITDA ratio of VAISHALI PHARMA is 43.54 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202443.54
Mar202314.35
Mar202210.28
Mar202111.55
Mar202019.03

How is EV/Core EBITDA of VAISHALI PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 43.54
203.41
Mar2023 14.35
39.59
Mar2022 10.28
-11.00
Mar2021 11.55
-39.31
Mar2020 19.03 -

Other Financial Ratios of VAISHALI PHARMA


Compare EV/Core EBITDA ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹124.8 Cr -1.6% -12.5% -48.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,477.0 Cr 2.7% 3.7% -6.1% Stock Analytics
DIVIS LABORATORIES ₹174,934.0 Cr -5.3% 0.6% 10% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,469.0 Cr 7.5% 8.1% 19.2% Stock Analytics
CIPLA ₹123,250.0 Cr 1.3% -2.7% -5% Stock Analytics
DR REDDYS LABORATORIES ₹103,038.0 Cr 2% -2.8% -7% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-1.6%

-12.5%

-48.2%

SENSEX

1.4%

2.4%

5.1%


You may also like the below Video Courses